Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent post-traumatic headache: a migrainous loop or not? The clinical evidence.
Labastida-Ramírez A, Benemei S, Albanese M, D'Amico A, Grillo G, Grosu O, Ertem DH, Mecklenburg J, Fedorova EP, Řehulka P, di Cola FS, Lopez JT, Vashchenko N, MaassenVanDenBrink A, Martelletti P; European Headache Federation School of Advanced Studies (EHF-SAS). Labastida-Ramírez A, et al. Among authors: di cola fs. J Headache Pain. 2020 May 24;21(1):55. doi: 10.1186/s10194-020-01122-5. J Headache Pain. 2020. PMID: 32448142 Free PMC article. Review.
Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study).
Vernieri F, Altamura C, Brunelli N, Costa CM, Aurilia C, Egeo G, Fofi L, Favoni V, Pierangeli G, Lovati C, Aguggia M, d'Onofrio F, Doretti A, Di Fiore P, Finocchi C, Rao R, Bono F, Ranieri A, Albanese M, Cevoli S, Barbanti P; GARLIT Study Group. Vernieri F, et al. J Headache Pain. 2021 May 3;22(1):35. doi: 10.1186/s10194-021-01247-1. J Headache Pain. 2021. PMID: 33941080 Free PMC article.
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
Vernieri F, Brunelli N, Marcosano M, Aurilia C, Egeo G, Lovati C, Favoni V, Perrotta A, Maestrini I, Rao R, d'Onofrio L, Finocchi C, Aguggia M, Bono F, Ranieri A, Albanese M, Di Piero V, Cevoli S, Altamura C, Barbanti P; GARLIT Study Group. Vernieri F, et al. Eur J Neurol. 2023 Jan;30(1):224-234. doi: 10.1111/ene.15563. Epub 2022 Sep 26. Eur J Neurol. 2023. PMID: 36097739 Free PMC article.
Clinical outcome of neurological patients with COVID-19: the impact of healthcare organization improvement between waves.
Cristillo V, Pilotto A, Benussi A, Libri I, Giunta M, Morotti A, Gipponi S, Locatelli M, Piccinelli SC, Mazzoleni V, di Cola FS, Masciocchi S, Pezzini D, Scalvini A, Premi E, Cottini E, Gamba M, Magoni M, Fontanella MM, Padovani A. Cristillo V, et al. Among authors: di cola fs. Neurol Sci. 2022 May;43(5):2923-2927. doi: 10.1007/s10072-022-05946-8. Epub 2022 Feb 17. Neurol Sci. 2022. PMID: 35175442 Free PMC article.
Neurological disorders throughout acute SARS-CoV2 infection: A comparative study between vaccinated and non-vaccinated patients.
Cristillo V, Pilotto A, Piccinelli SC, Libri I, Locatelli M, Giunta M, Mazzoleni V, Pezzini D, Arici D, Gipponi S, di Cola FS, Cottini E, Gamba M, Magoni M, Padovani A. Cristillo V, et al. Among authors: di cola fs. J Neurol Sci. 2024 Feb 15;457:122898. doi: 10.1016/j.jns.2024.122898. Epub 2024 Jan 23. J Neurol Sci. 2024. PMID: 38281402